Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial ResultsBusiness Wire (press release)
(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTC: PRWP), the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for full year and fourth quarter, ended December 31, 2010. ...
and more »